How do scarring and clips from a robotic partial nephrectomy (partial kidney removal) appear on ultrasound in a patient with a history of kidney cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ultrasound Appearance of Scarring and Clips After Robotic Partial Nephrectomy

Scarring from robotic partial nephrectomy appears on ultrasound as a permanently visible echogenic (bright) area at the resection site, often with irregular capsular contour and parenchymal defect, while surgical clips manifest as highly echogenic foci with posterior acoustic shadowing. 1, 2

Expected Ultrasound Features of Post-Surgical Changes

Parenchymal Scarring

  • The surgical scar appears as an echogenic (hyperechoic) area corresponding to the resection site, with the degree of echogenicity depending on the extent of tissue removal and healing 2
  • The capsular surface shows irregularity or indentation at the surgical site, creating a visible defect in the normal smooth renal contour 1
  • The extent of scarring directly correlates with surgical technique: simple enucleation produces minimal scarring, enucleoresection creates moderate scarring, and wedge/polar resection results in more extensive echogenic changes 2

Surgical Clips

  • Hemostatic clips appear as highly echogenic (very bright) foci with characteristic posterior acoustic shadowing that obscures structures behind them 2
  • Multiple clips may be present along the resection margins where the modified pledget clip technique was used for parenchymal reconstruction 3, 4
  • Clips remain permanently visible and should maintain stable position over time 1

Establishing the Baseline

Obtain baseline imaging at 3-12 months post-surgery to document the stable post-operative appearance, which serves as the reference for all future surveillance 3, 1

  • This baseline scan captures the permanent surgical defect after initial healing is complete 1
  • The scar does not disappear but stabilizes in size and echogenicity after the healing period 1
  • All future imaging should be compared to this baseline, not the pre-operative studies 1

Distinguishing Normal Scarring from Complications

Normal Post-Surgical Findings

  • Stable echogenic area at the known surgical site that does not change in size or appearance over serial examinations 1
  • Wedge-shaped defect with irregular capsular contour corresponding to the resection site 1
  • Echogenic clips with shadowing in expected locations based on operative reports 2

Concerning Findings Requiring Further Evaluation

  • Progressive enlargement of the surgical bed or echogenic area suggests local recurrence rather than stable scarring 3, 1
  • New nodularity or mass effect in or around the treated zone warrants investigation for recurrence 3
  • Perinephric fluid collections may indicate perirenal hematoma (early post-op) or urinoma from urinary fistula 3, 2
  • Any enhancement on Doppler interrogation within the scar raises concern for viable tumor tissue 3, 1

Critical Pitfalls to Avoid

Misinterpreting Stable Scarring as Disease

  • Do not mistake the permanent surgical defect for progressive disease - the scar remains visible indefinitely and stability is the key feature 1
  • Establish the 3-12 month baseline scan before concluding any changes represent recurrence 1
  • The surgical defect will not "fade away" - surveillance focuses on stability, not resolution 1

Technical Imaging Considerations

  • Use the same imaging modality (ultrasound, CT, or MRI) for serial comparisons to accurately detect true changes 1
  • Correlate echogenic foci location with operative reports and known tumor position to distinguish expected scarring from complications 2
  • Consider timing and clinical symptoms when interpreting findings - early post-operative collections may represent hematoma, while late changes suggest recurrence 2

Small Echogenic Masses

  • Not all small echogenic renal masses are benign - some renal cell carcinomas (particularly those <2 cm) appear very hyperechoic and could be mistaken for angiomyolipomas or scar tissue 5
  • In the post-nephrectomy setting, any new echogenic focus outside the expected surgical bed warrants investigation 3, 1

Surveillance Protocol

Follow NCCN recommendations for post-partial nephrectomy surveillance based on tumor stage 3, 1:

  • Annual abdominal imaging (ultrasound, CT, or MRI) for 3 years after the baseline scan 3, 1
  • Beyond 3 years, imaging at physician discretion based on individual risk factors 3, 1
  • Any change in the surgical site appearance (size increase, new nodularity, enhancement) requires immediate further evaluation with contrast-enhanced CT or MRI 3, 1

References

Guideline

Duration of Visible Scarring After Partial Nephrectomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Robotic Partial Nephrectomy Outcomes and Scarring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Surgical Steps for Partial Nephrectomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Renal Cell Carcinomas: Sonographic Appearance Depending on Size and Histologic Type.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2016

Related Questions

How is scarring from robotic partial nephrectomy (minimally invasive surgical procedure for kidney disease or cancer) described on an ultrasound in an adult patient?
How is a small renal cell carcinoma (renal cell cancer) typically described on an ultrasound in a menopausal woman with a history of sporadic angiomyolipoma (a type of non-cancerous kidney tumor)?
Can a 5 mm kidney stone be differentiated from a tumor on an ultrasound?
What is the likelihood that a 5mm echogenic focus in the kidney is benign?
Are echogenic foci and tumors the same thing in a patient with a history of robotic partial nephrectomy (kidney surgery)?
What is the best course of treatment for an elderly patient with stage 3 non-small cell lung cancer (NSCLC) who is experiencing recurring pneumonia after undergoing a bilobectomy?
Is C3-4 Anterior Cervical Discectomy and Fusion (ACDF) surgery medically indicated for a 66-year-old patient with severe C3-4 spinal stenosis, right-sided weakness, right hand clumsiness, and ataxia, who also has severe spinal stenosis at C4-5?
Can a scopolamine (transdermal antiemetic) patch cause seizures in a patient with a history of seizure disorders or neurological conditions who is on morphine (opioid analgesic) for pain management?
What is the procedure for performing an emergency thoracotomy in an unresponsive adult patient with a penetrating chest injury, cardiac arrest, and signs of cardiac tamponade or massive hemothorax?
What is the best treatment approach for a patient with occipital neuralgia, considering their potential history of inflammatory conditions such as rheumatoid arthritis?
Can intramuscular (IM) adrenaline be given to an adult patient in a primary setup with hypotension (low blood pressure) that is unresponsive to initial fluid resuscitation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.